Yunkwon Nam
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Tryptophan and brain disorders 4
- Physiology 25
- Alzheimer's disease research and treatments 23
- Co-authors
- Minho MoonSoo Jung ShinSeong Gak JeonSujin KimHyeon soo KimYong Ho ParkYong‐Ho ParkSang Bum Hong
- Journals
- International Journal of Molecular Sciences (7 papers)Biomedicine & Pharmacotherapy (5 papers)Biomedicines (3 papers)Translational Neurodegeneration (3 papers)Frontiers in Aging Neuroscience (2 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Yunkwon Nam
33 papers receiving 696 citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Biological Psychiatry 106
- Neurology 120
- Physiology 303
- Developmental Neuroscience 31
- Complementary and alternative medicine 60
Countries citing papers authored by Yunkwon Nam
This map shows the geographic impact of Yunkwon Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunkwon Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunkwon Nam more than expected).
Fields of papers citing papers by Yunkwon Nam
This network shows the impact of papers produced by Yunkwon Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunkwon Nam. The network helps show where Yunkwon Nam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yunkwon Nam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 11 | |
| 3 | Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives Hit paper breakdown → | 2025 | 39 |
| 4 | 2025 | 1 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 14 | |
| 15 | 2021 | 42 | |
| 16 | 2021 | 100 | |
| 17 | 2020 | 13 | |
| 18 | 2020 | 32 | |
| 19 | 2019 | 13 | |
| 20 | 2018 | 38 |
About Yunkwon Nam
Yunkwon Nam is a scholar working on Biological Psychiatry, Physiology, Neurology, Developmental Neuroscience and Pharmacology, having authored 34 papers that have together received 697 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (23 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Ginseng Biological Effects and Applications (5 papers), Pharmacological Effects of Natural Compounds (5 papers), Natural product bioactivities and synthesis (4 papers), Tryptophan and brain disorders (4 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Biological Psychiatry (106 citations), Neurology (120 citations), Physiology (303 citations), Developmental Neuroscience (31 citations) and Complementary and alternative medicine (60 citations). Yunkwon Nam has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Minho Moon, Soo Jung Shin, Seong Gak Jeon, Sujin Kim, Hyeon soo Kim, Yong Ho Park, Yong‐Ho Park, Sang Bum Hong, Jin-il Kim and Yong Yook Lee. Their work appears in journals such as International Journal of Molecular Sciences, Biomedicine & Pharmacotherapy, Biomedicines, Translational Neurodegeneration and Frontiers in Aging Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.